Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
Following publication of the original article [1] the authors reported that the first affiliation ( “Medical Center of the Graduate School, Nanchang University, China”) had been added in error, and that the cor...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Honghong Zou, Baoqin Zhou and Gaosi Xu Tags: Correction Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Graduation | Heart | SGLT2 Inhibitors | Urology & Nephrology